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Background. In a previous study, nitric oxide synthases (NOS)
were found to be strongly expressed in the tubular epithelium of
kidneys of a transgenic mouse model of sickle cell disease
(aHbS[bMDD]). Because NOS activity is often associated with
peroxynitrite formation when superoxide radical (zO22) is present
in abundance, we examined the kidneys of sickle cell mice for
nitrotyrosine, considered to be a footprint of ONOO2.
Methods. Western blot and immunohistochemistry for nitroty-
rosine was carried out. Since peroxynitrite and other reactive
oxygen radicals are capable of causing apoptosis, we also per-
formed agarose gel electrophoresis of kidney DNA and TUNEL
staining of nuclei, indicators of apoptosis.
Results. Nitration of tyrosine residues of three proteins (kD 66,
57 and 22) was found on Western blot of kidney protein extracts
of the sickle cell mice. The degree of tyrosine nitration of the 66
kD protein was not significantly different in the control versus
transgenic mice, whereas tyrosine nitration of the 57 and 22 kD
proteins was clearly increased in transgenic mice. Strong immu-
nostaining for nitrotyrosine was seen in tubular epithelial cells of
the sickle cell mice, in close proximity to positive immunostaining
of iNOS. Neither iNOS nor nitrotyrosine was expressed in the
control mice. DNA “laddering” was found localized to the same
zones of the kidney as nitrotyrosine and iNOS immunostaining.
TUNEL assay on mouse kidney tissue sections showed minimal
tubular cell apoptosis in normal mouse with hypoxia, mild tubular
cell apoptosis in sickle cell mouse in room air, and moderate
tubular cell apoptosis in sickle cell mouse with hypoxia.
Conclusions. The observations suggest that ONOO2 and per-
haps other reactive oxygen species are being produced in the
sickle cell kidney. The mechanism may be ischemia/reperfusion
due to intermittent vascular occlusion by sickle cells. The resulting
hypoxia could result in iNOS activation, superoxide radical and
peroxynitrite formation. Two consequences of these reactions
appear to be nitration of tyrosine residues of some renal proteins
and enhanced apoptosis.
Several clinical observations in sickle cell patients sug-
gest that nitric oxide (NO) synthesis is increased. These
include low blood pressure [1], renal hyperperfusion de-
spite elevated renin/angiotensin blood levels [2–6] and
priapism [7, 8], abnormalities that have been associated
with an increase in NO production in other clinical condi-
tions. In addition, plasma nitrite, a stable metabolic prod-
uct of NO, was found to be elevated in patients during
sickle cell crisis [9], a finding consistent with augmented
production of NO.
Our laboratory previously studied two of the isoenzymes
responsible for NO synthesis, the endothelial cell constitu-
tive isoform (ecNOS) and the macrophage inducible iso-
form (iNOS), in the kidneys of a transgenic mouse model of
sickle cell disease (aHbS[bMDD]) [10]. Expression of both
were increased [10]. The mechanism of the induction of
these enzymes was postulated to be hypoxia secondary to
vasoocclusion of small blood vessels within the kidney [10].
It has become evident that under certain experimental
conditions, increased NOS activity is associated with pro-
duction of several reactive oxygen species, such as super-
oxide radical (zO2
2), lipid peroxyl radicals (LOO2), hy-
droxyl radical (OHz) and peroxynitrite (ONOO2) [11].
Peroxynitrite in particular has been postulated to be re-
sponsible for several of the cytotoxic effects previously
ascribed to NO under several clinical and experimental
conditions [12–15]. For example, in NOS-transfected hu-
man renal tubular epithelial cells, eliminating L-arginine
from the medium was found to result in ONOO2 produc-
tion, nitrotyrosine formation, and cellular injury [16]. Renal
injury caused by cross-clamping of the renal pedicle of rats
and mice, followed by reperfusion, was also found to result
in renal iNOS and nitrotyrosine expression [17]. Ischemia-
reperfusion injury of isolated rat hearts has also been
associated with production of ONOO2 and nitrotyrosine
formation [18].
To evaluate whether increased iNOS expression is asso-
ciated with formation of peroxynitrite in sickle cell ne-
phropathy, we examined the kidneys of bS transgenic sickle
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cell mice for expression of a marker of ONOO2, that is,
nitrotyrosine. Since ONOO2 is a potent agent for cell
injury, we also carried out DNA electrophoresis and
TUNEL staining of cell nuclei in order to assess apoptosis.
Strong nitrotyrosine and iNOS immunostaining was found
in renal epithelial cells of the medulla of sickle cell mouse
kidneys, and nitration of tyrosine residues of several pro-
teins on Western blot. DNA electrophoresis and TUNEL
staining showed extensive evidence of apoptosis in the
outer and inner medullary regions. The observations indi-
cate that increased activity of iNOS in the kidneys of sickle
cell mice is associated with peroxynitrite formation, which
may be responsible for accelerated apoptosis.
METHODS
The methods to establish the bS transgenic line of sickle
cell mice used in this study have been described previously
[19, 20]. This line was created by the simultaneous micro-
injection and cointegration of constructs of the locus
control regions of the genes responsible for bS and a
hemoglobin chains, on a normal mouse background. The
mice with stable expression of aH and bS were bred for
seven or more generations onto the C57BL/6J background.
To achieve higher levels of bS expression, the transgenic
mice were bred with a strain of mice bearing a spontaneous
deletion of the mouse bmajor-globin gene. When the bmajor
deletion was bred to homozygosity, expression of bS in-
creased to an average of 72.7% [19]. The final mouse model
is designated as aHbS[bMDD], indicating the double dele-
tion of mouse bmajor-globin. The control mice used in this
study were of the C57BL/6J strain [20] purchased from
Jackson Laboratories (Bar Harbor, ME, USA).
All animals were allowed free access to a mouse pellet
diet and water. The mice were between 6 and 10 months of
age and weighed between 30 and 40 g at the time of study.
They were housed in individual cages under room air
conditions or under hypoxic conditions for four to five days
in glass environmental chambers (Braintree Scientific,
Braintree, MA, USA) filled with constantly flowing 10%
O2/0.5% CO2/89.5% N2 gas. Since the b
S transgenic mice
manifest low levels of sickling and medullary vasoocclusion
under room air conditions, we exposed half of the trans-
genic mice to chronic hypoxia to increase in vivo sickling
and renal medulla and papillary vasoocclusion, as previ-
ously reported [20, 21]. The other bS mice were housed in
ambient room air in individual metabolic cages. Control
mice were also exposed to chronic hypoxia in order to
distinguish between the effects of hypoxia per se versus
vasoocclusion of intrarenal blood vessels, which occurs only
in the sickle cell mice [20]. In each of the protocols
described below, groups of four mice (2 control, 2 trans-
genic) were studied simultaneously to minimize variability
due to biological supplies.
On the day of study, the mice were anesthetized with
ether, the kidneys were rapidly excised through a midline
incision and blood was drained from the severed renal
artery and vein during washing in ice-cold homogenizing
buffer. Kidneys for immunohistochemistry were fixed in
10% buffered formalin. Kidneys for DNA extraction and
electrophoresis were frozen immediately in liquid nitrogen.
Kidneys for Western blot were prepared immediately.
Sample preparation and protein extraction
Kidneys were homogenized (Ultra Turrax T25; IKA-
Labortechnik, Staufen, Germany) in 2 ml of ice-cold ho-
mogenizing buffer, (pH 7.5, Tris 50 mM, NaCl 20 mM,
EDTA 1 mM, NP-40 0.3%), and 0.1 ml/g kidney wt of a
protease inhibitor cocktail consisting of 4-(2-aminoethyl)
benzenesulfonyl fluoride (AEBSF), pepstatin A, trans-
epoxysuccinyl-L-leucylamido (4-guanidino) butane (E-64),
bestatin, leupeptin, and aprotinin (Sigma Chemical Co., St.
Louis, MO, USA). The homogenates were centrifuged at
10,000 rpm at 4°C for 20 minutes. The supernatant was
collected and was again centrifuged at 10,000 rpm for two
minutes. The protein concentration of the supernatant was
determined by the Bradford method (BioRad). Sixty mg of
protein was used per well and volume adjusted with SDS
loading buffer (62.5 mM Tris-HCl, glycerol 10%, bromphe-
nol blue 1% wt/vol, SDS 2%, mercaptoethanol 2.5%).
Samples were then boiled for two to three minutes before
loading on 12% SDS separating gel. Electrophoresis was
carried out for one hour at 200 volts. Transfer of proteins
to nitrocellulose or PVDF membranes was performed at
100 volts for one hour in transfer buffer (25 mM Tris, 192
mM glycine, and 5% methanol).
Western blot
Membranes were blocked in TBS (pH 7.5, 20 mM Tris,
140 mM sodium chloride) containing 3% non-fat milk
(TBS-MLK) for 30 minutes with constant agitation, and
then were incubated overnight at 4°C with 1 mg/ml of a
mouse IgG monoclonal nitrotyrosine antibody (Upstate
Biotechnology, Lake Placid, NY, USA) diluted in freshly
prepared TBS-MLK. A positive control was carried out
with each experiment, consisting of a range of molecular
weight protein standards that had been tyrosine nitrated
(supplied by Upstate Biotechnology). Negative control was
carried out by preincubating the primary antibody with 10
mM nitrotyrosine (30 min, 20°C; Sigma) and adjusting the
pH to 7.2. Membranes were washed twice with water and
incubated with goat or sheep anti-mouse IgG linked to
horseradish peroxidase (1:2000 dilution in TBS-MLK; Am-
ersham) for 1.5 hours at room temperature. Membranes
were washed first with water and then TBS-0.05% Tween
for five minutes. They were then rinsed five times in water.
ECL (Amersham) was used as the visualization method.
Immunohistochemistry
Kidney tissue sections from control and bS transgenic
mice were processed simultaneously for immunostaining of
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nitrotyrosine and iNOS. Simultaneous processing, using
identical reagents and timing, permits semiquantitative
comparisons of staining intensity. Four to 6 micron-thick
sections of formalin-fixed kidneys were cut, dewaxed twice
in xylene, rehydrated in ethanol, and washed. Adjacent
sections from each kidney were examined with affinity
purified polyclonal antibodies directed against mouse mac-
rophage inducible nitric oxide synthase (iNOS) or a rabbit
polyclonal IgG antibody directed against nitrotyrosine.
Nitrotyrosine. Formalin-fixed sections were placed in
0.03% H2O2 in methanol for 30 minutes to neutralize
endogenous peroxidases and were blocked with normal
goat serum containing 0.5% BSA for 30 minutes. They
were then washed in PBS for 15 minutes, and the primary
antibody (1:100 dilution of immunoaffinity purified rabbit
polyclonal IgG directed against nitrotyrosine; Upstate Bio-
technology, Lake Placid, NY, USA) was added and incu-
bated at 4°C overnight in a humidified chamber. The
secondary antibody was 1% goat biotinylated anti-rabbit
IgG-biotin, visualized by reaction with avidin-biotin perox-
idase (Vectastain Elite ABC kit, Vector Labs, Burlingame,
CA, USA). The sections were then incubated with fresh
diaminobenzidine tetrahydrochloride (DAB) solution (Sig-
ma) for seven minutes at room temperature. Positive
controls were carried out on kidney sections from normal
control mice by incubation with a peroxynitrite solution,
following instructions of Upstate Biotechnology. After in-
cubation, the primary and secondary antibodies were added
as above. Negative controls were performed by exposure of
slides from transgenic mouse kidneys to 10 mM nitroty-
rosine in PBS, which blocks binding of the first antibody.
Reagents for the positive and negative controls were ob-
tained from Upstate Biotechnology. Sections were counter-
stained with hematoxylin for 30 to 45 seconds.
iNOS. Kidney slices adjacent to those that had been used
for nitrotyrosine were examined for iNOS immunostaining.
The slides were heated at 60°C for 30 minutes, washed in
xylene, 100% ethanol, 95% ethanol and fixed in 4% forma-
lin for 30 minutes at room temperature. Nonspecific bind-
ing was blocked with normal goat serum containing 0.5%
BSA. The slides were then incubated with an affinity-
purified mouse macrophage polyclonal iNOS antibody
raised in rabbits (Transduction Laboratories, Lexington,
KY, USA), 16 mg/ml in PBS at 4°C overnight in a humid-
ified chamber. The secondary antibody (biotinylated anti-
rabbit antibody) was added and incubated for one hour at
room temperature. An alkaline phosphatase substrate was
then applied (Vectastain ABC-AP reagent and Vector red
substrate kit; Vector Laboratories) and incubated in the
dark for 25 minutes. The resulting diazo compound is
intensely red. The slides were counterstained with hema-
toxylin for 45 seconds at room temperature. Procedures
recommended by Vector were closely followed.
Slides from each kidney, incubated with either nitroty-
rosine or iNOS antibody, were examined consecutively.
Closely comparable areas of each kidney, stained with one
of the two primary antibodies, were photographed at 3100
magnification, using a Nikon HFX-DX microscope equipped
with an automated Nikon camera system, NFX-35. A blue
filter was used to accentuate the contrast between positive
staining and background staining and to select areas for
photography.
Renal cortical DNA isolation and gel electrophoresis
The renal cortex of kidneys was dissected away from the
rest of the kidney, and the cortical tissue was lysed in DNA
lysis buffer (1% Nondet P-40 in 20 mM EDTA, 50 mM
Tris-HCl, pH 7.5, 10 ml per 106 cells, minimum 50 ml).
Lysates were centrifuged for five minutes, 1600 3 g,
supernatants were collected and extractions were repeated.
The supernatants were brought to 1% SDS, treated with
RNAse for two hours at 56°C and digested with proteinase
K for two hours at 37°C. Ammonium acetate (10 mM), 1/2
volume was added and DNA precipitated with 2.5 volumes
of 100% ETOH. Pellet was dissolved in TE buffer and
separated by electrophoresis in 1.6% agarose gel at room
temperature.
TUNEL assay
We used the ENZO ApopDETEK cell death assay
system to locate the occurrence of renal cell apoptosis in
tissue sections. This system provides a very high quality
terminal deoxynucleotide transferase to incorporate Bio-
16-dUTP onto the 39-OH termini in the DNA of the
Fig. 1. Top: Densitometric quantification of tyrosine nitration of the 57
kD protein expressed as the ratio of the means compared to normal mice
from 7 groups of 4 mice each. Bottom: Western blot of renal protein
extracts using a monoclonal antibody directed against nitrotyrosine (ex-
posure 1 min). Lane 1, normal mouse; lane 2, hypoxic normal mouse; lane
3, sickle cell mouse; lane 4, hypoxic sickle cell mouse.
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specimen. The incorporated Bio-16-dUTP is then detected
with horseradish peroxidase-aminoethylcarbazole in situ
detection system. In brief, paraffin tissue sections from
control and experimental mice were deparaffinized and
permeabilized with proteinase K. Endogenous peroxidase
activity was inactivated by treating the tissue sections with
0.5 ml of Quench Reagent (ENZO Diagnostics, Inc.,
Farmingdale, NY, USA). Sections were incubated with
equilibration buffer followed by a reaction mixture (termi-
nal transferase) for 30 minutes. Slides were washed with
wash buffer and treated with reagents supplied in the
ENZO horseradish peroxidase-aminoethylcarbazole in situ
detection kit. Slides were examined under a light micro-
scope and graded for the occurrence of apoptosis.
RESULTS
Western blots
Figure 1 (bottom) shows a Western blot of renal protein
extracts of mouse kidneys, using a monoclonal antibody
directed against nitrotyrosine. Three different molecular
weight proteins were detected by the antibody, correspond-
ing approximately to 66, 57 and 22 kD. Tyrosine nitration of
the 66 kD band was not significantly different in the normal
versus the transgenic mice. However, tyrosine nitration of
both the 57 and 22 kD proteins was clearly increased in the
transgenic mice, especially when exposed to 10% O2 for
five days. The densitometric quantification of nitrotyrosine
of the 57 kD protein, shown in the upper portion of Figure
1, represents the analysis of seven groups of four mice each.
Nitration of the 57 kD protein was increased on average by
1.8-fold in transgenic mice versus control mice maintained
in room air (P , 0.01), and by 9.2-fold in the transgenic
mice exposed to hypoxic conditions (P , 0.001). Nitration
of the 22 kD protein was observed only in some immuno-
blots of transgenic mice housed in room air, but was
observed consistently in the transgenics exposed to hypoxic
conditions. No nitration of the 22 kD protein was seen in
normal control mice. Preincubation of anti-nitrotyrosine
antibody with excess 3-nitrotyrosine (10 mM) completely
blocked the immunoreactivity of the proteins (results not
shown). Coomassie blue stained SDS gels confirmed that
similar amounts of proteins were loaded in each lane.
Immunohistochemistry
Sections of normal and transgenic sickle cell mouse
kidneys stained for nitrotyrosine are shown in Figure 2. No
staining was found in any of the four control C57BL/6J
mice (Fig. 2A), whereas strongly positive staining was
evident in all eight sickle cell mice studied. Nitrotyrosine
was found in tubular epithelial cells in both the cortex and
medulla, but strongest staining was seen in the inner
medulla and papilla (Fig. 2 C, D). Figure 2B shows a
Fig. 2. Immunohistochemistry staining of nitrotyrosine in mouse renal medulla and papilla. (A) Normal mouse. (B) bS sickle cell mouse, negative
control (Methods section). (C) bS sickle cell mouse renal medulla. (D) bS sickle cell mouse renal papilla.
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Fig. 3. Paired immunohistochemistry staining of both inducible nitric oxide synthase (iNOS) and nitrotyrosine in individual kidneys of normal and
bS sickle cell mice. Paired photomicrographs are from closely adjacent areas.
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negative control carried out on a section of a sickle cell
mouse kidney in which the slide was incubated with 3-ni-
trotyrosine before addition of the primary antibody. This
clearly blocked reaction with the primary antibody. Positive
controls consisted of kidney sections of normal mice incu-
bated with peroxynitrite prior to carrying out immunohis-
tochemistry. This was found to result in positive immuno-
staining of tubular epithelial cells (not shown).
Figure 3 compares the immunostaining of nitrotyrosine
with iNOS in closely adjacent paired kidney sections of four
mice. The results are representative of three additional
groups of four mice each. Under room air conditions, no
staining for either nitrotyrosine or iNOS was found in the
normal mice. Exposure of normal mice to hypoxia for four
to five days resulted in scattered iNOS staining in a few
distal nephron segments in the cortex and medulla, but no
nitrotyrosine staining was seen. In contrast, in the sickle cell
mice, strongly positive immunoreactivity was observed for
both iNOS and nitrotyrosine under both room air and
chronic hypoxic conditions. The nitrotyrosine staining was
strongest in the luminal membrane, but was also expressed
in the basolateral membrane. The glomeruli were negative.
Positive staining for nitrotyrosine was also found in the
walls of blood vessels, as shown in Figure 3. The iNOS
immunostaining in sickle cell mouse kidneys is similar to
that reported previously by our laboratory [10].
DNA electrophoresis
Figure 4 shows an agarose gel electrophoresis of DNA
extracted from cortical tissue. As can be seen, there was no
strand breakage of DNA in control mice housed under
either room air or hypoxic conditions. In sharp contrast,
multiple nucleoendosome bands were seen in the gels of bS
mouse kidneys, indicating extensive double strand breakage.
TUNEL assay for apoptosis
Figure 5 shows representative photomicrographs of
TUNEL-positive apoptotic cells in the sections of renal
medulla of sickle cell mice maintained under room air
conditions as well as hypoxic conditions. It is evident that
uptake of Bio-16-dUTP occurred in the nuclei of bS mouse
epithelial cells, the number of effected cells being greater in
the hypoxic bs mouse. Most of the positive nuclei were in
the medullary collecting ducts, but were also seen in the
cortex in smaller numbers. As can be seen in Figure 5A, no
evidence of DNA nicking was evident in the control mouse,
but low grade evidence of apoptosis was present in the
hypoxic control mouse (Fig. 5B).
DISCUSSION
The major end product of the reaction between L-
arginine and nitric oxide synthases is nitric oxide (NO). NO
synthesis depends on an adequate supply of the precursor,
L-arginine, and several co-factors including molecular ox-
ygen, NADPH and tetrahydrobiopterin [22–26]. Under
experimental conditions of severe L-arginine depletion [16,
27, 28], or ischemia/reperfusion of the heart, lung or kidney
[17, 18, 29], there is induction of NOS, increased superox-
ide radical production, and formation of the potent oxidiz-
ing agent, peroxynitrite. Tissue injury that occurs under
these experimental conditions has been attributed by a
number of investigators to peroxynitrite, since immuno-
staining or increased immunoblot evidence of nitrotyrosine
was found in these studies [reviewed in 30]. Nitrotyrosine
formation results from the specific reaction between per-
oxynitrite (ONOO2) and tyrosine residues of various pro-
teins [30, 31], and therefore nitrotyrosine serves as pre-
sumptive evidence of ONOO2 formation.
In the present study, we examined the kidneys of a
transgenic mouse model of sickle cell disease (aHbS[bMDD])
for evidence of nitrotyrosine expression, by Western blot
and immunohistochemistry. As shown in Figure 1, nitroty-
rosine reaction was found in two protein bands in normal
mice whereas three distinct bands were seen in the trans-
genic mouse kidney extracts. The presence of nitrated
proteins in normal conditions is not surprising as it has
been reported previously [32], and may possibly derive
from low levels of NO and O22 produced constitutively.
The level of tyrosine nitration was quantitatively greater in
kidney protein extracts from sickle cell mice, and exposure
of these mice to hypoxia led to a further marked increase
(Fig. 1). Exposure of control mice to hypoxia did not
consistently alter tyrosine nitration. Since the mouse IgG
monoclonal antibody detects the quantity of nitrated ty-
rosine residues, the increased reaction seen in the sickle
Fig. 4. Agarose gel electrophoresis of DNA extracted from renal cells.
Lane 1, 123 kb marker; lane 2, normal mouse; lane 3, sickle cell mouse;
lane 4, hypoxic normal mouse; lane 5, hypoxic sickle cell mouse.
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cell mice could be due to either increased quantities of
protein in the transgenic mice or to increased nitration of
similar protein quantities. The Western blots do not distin-
guish between these two possibilities. However, there were
no differences in protein quantities loaded onto each lane
when examined in Coomassie blue-stained SDS gels (not
shown). Hence, the increased expression of nitrotyrosine
on Western blot presumably reflects increased nitration of
tyrosine residues of equal quantities of protein.
Representative immunohistochemistry results, shown in
Figures 2 and 3, demonstrate that nitrotyrosine staining was
strongly positive in the bS mice but was minimal or absent
in the normal mice. Positive staining was observed in
cortical distal nephron segments, the outer and inner
medulla, and the papilla of the transgenic mice, whereas in
normal control mice, no immunostaining for nitrotyrosine
was found under either room air or hypoxic conditions.
These observations provide strong presumptive evidence
for formation of peroxynitrite in the tubular epithelial cells
of sickle cell mice, and confirm the findings of nitrotyrosine
on Western blot. In addition, paired staining for iNOS
showed that the zones of the kidney where nitrotyrosine
staining was found were in close proximity to those where
iNOS was seen (Fig. 3). Staining for both was found in
cortical collecting tubules, and collecting ducts of the outer
and inner medulla and papilla. The photomicrographs in
Figure 3 show iNOS and nitrotyrosine reactions in the same
kidney of each of the four mice, focused on closely com-
parable regions, although they do not represent precise
co-localization. These observations nevertheless suggest
Fig. 5. Occurrence of apoptosis in mouse renal medulla detected by TUNEL method. TUNEL-positive cells are indicated by arrows. (A) Normal mouse.
(B) Hypoxic normal mouse. (C) Sickle cell mouse. (D) Hypoxic sickle cell mouse.
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that there may be site-specific localized production of NO
and ONOO2 that leads to nitrotyrosine formation in
closely adjacent regions. Consistent with this view is the
recent report of Bosse and Bachmann, who found evidence
of co-localization of nitrotyrosine and NOS activity in
kidneys of rats with unilateral renal artery stenosis [33].
A number of studies have shown that peroxynitrite can
mediate DNA double strand breakage, an expression of
apoptosis [34–38]. In the kidney, histologic evidence of
apoptosis and/or DNA “laddering” has been demonstrated
in proximal tubular epithelial cells [39] and mesangial cells
[40] under several different experimental conditions, such
as exposure to H2O2 [39, 40], ischemia/reperfusion injury
[41, 42] and transplant rejection [43]. The common denom-
inator in these conditions is thought to be enhanced
production of reactive oxygen species, such as zO2
2, H2O2,
OHz and ONOO2 in excess of endogenous antioxidant
protection [30, 34, 44, 45]. As shown in Figure 4, DNA
strand breakage was clearly present in the sickle cell mouse
kidneys and apoptosis by TUNEL assay.
The mechanism of ONOO2 and nitrotyrosine formation
in the sickle cell mice is not yet clear. In isolated NOS-
transfected human kidney epithelial cells, depletion of
L-arginine resulted in a fall in NO and a rise in zO2
2
production, accompanied by peroxynitrite formation and
evidence of cell toxicity [16]. A similar sequence of events
was found in murine macrophages depleted of cytosolic
L-arginine [28]. Although L-arginine depletion has not
been demonstrated in whole tissues or organs, it is conceiv-
able that this may occur in some pathological conditions.
The source of L-arginine in the kidney is most likely that
which is synthesized in renal tubular cells from citrulline
and aspartate, utilizing ATP [46]. The quantity of arginine
normally used in NO production by the constitutive iso-
forms of NOS is very small as compared with that utilized
in intermediary metabolic reactions [46]. Therefore, it is
very unlikely that arginine deficiency would develop under
physiological conditions. Moreover, citrulline, an end-prod-
uct of NO production, can be re-cycled for regenerating
arginine. However, when iNOS is induced and the high
output pathway of NO synthesis is activated, L-arginine
concentrations may become rate-limiting, favoring synthe-
sis of zO2
2 rather than NO. (The Km for the L-arginine
reaction with iNOS is 2.8 mM [47].) ATP is required for
L-arginine synthesis [46], and ischemia/reperfusion injury
due to vasoocclusion might deplete ATP levels. In addition,
recent studies have shown that experimental conditions
that induce iNOS, including hypoxia, can also increase
arginase activity [48, 49] in some tissues. Increased arginase
activity could contribute to lowering cytosolic level of
L-arginine. Alternatively to this hypothesis, a rise in tissue
zO2
2 may occur due to reduced endogenous dismutases or
to increased production via other chemical reactions,
thereby providing the necessary concentrations of zO2
2 for
ONOO2 formation.
The finding of apoptosis and nitrotyrosine formation in
the transgenic sickle cell kidney may be causally related to
some of the functional and histologic pathology in this
disease. Ischemia/reperfusion-mediated apoptosis could re-
sult in tubulointerstitial changes, loss of functioning
nephrons, and eventual scarring [50, 51]. Thus, structural
damage in sickle cell kidneys may be the consequence of
hypoxia-induced iNOS activity and superoxide formation,
leading to peroxynitrite formation and accelerated apopto-
sis.
The functional consequences of nitration of the renal
protein tyrosine residues found on Western blot are pres-
ently unknown. In other systems, nitration of tyrosine
residues by peroxynitrite has been found to inactivate
prostacyclin synthase [52], to interfere with tyrosine phos-
phorylation signal transduction [53, 54], to inhibit epider-
mal growth factor receptor tyrosine kinase [55], and to
inactivate aconitase [56]. Whether these and/or other func-
tional disturbances result from tyrosine nitration in the
sickle cell kidney will require further study.
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APPENDIX
Abbreviations used in this paper are: AEBSF, 4-(2-aminoethyl) ben-
zenesulfonyl fluoride; ATP, adenosine 59-triphosphate; DAB, diamino-
benzidine tetrahydrochloride; ecNOS, endothelial cell constitutive iso-
form of nitric oxide synthesis; iNOS, inducible isoform of nitric oxide
synthase; LOO2, lipid peroxyl radicals; NO, nitric oxide; zO2
2, superoxide
radical; OHz, hydroxyl radical; ONOO2, peroxynitrite; TUNEL, terminal
deoxytransferase uridine triphosphate nick end-labeling.
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